BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Li X, Cao K, Deng H, He Y, Liao Q, Xiang B, Zhou M, Guo C, Zeng Z, Li G, Xiong W. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39:204. [PMID: 32993787 DOI: 10.1186/s13046-020-01709-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou B, Lu D, Wang A, Cui J, Zhang L, Li J, Fan L, Wei W, Liu J, Sun G. Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;26:1051-65. [PMID: 34786210 DOI: 10.1016/j.omtn.2021.09.014] [Reference Citation Analysis]
2 Qi S, Deng S, Lian Z, Yu K. Novel Drugs with High Efficacy against Tumor Angiogenesis. IJMS 2022;23:6934. [DOI: 10.3390/ijms23136934] [Reference Citation Analysis]
3 Luo K, Zhang L, Liao Y, Zhou H, Yang H, Luo M, Qing C. Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review). Oncol Rep 2021;45:824-34. [PMID: 33432368 DOI: 10.3892/or.2021.7927] [Reference Citation Analysis]
4 Herrera-Vargas AK, García-Rodríguez E, Olea-Flores M, Mendoza-Catalán MA, Flores-Alfaro E, Navarro-Tito N. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev 2021:S1359-6101(21)00078-2. [PMID: 34736827 DOI: 10.1016/j.cytogfr.2021.10.006] [Reference Citation Analysis]
5 Scarpellino G, Genova T, Quarta E, Distasi C, Dionisi M, Fiorio Pla A, Munaron L. P2X Purinergic Receptors Are Multisensory Detectors for Micro-Environmental Stimuli That Control Migration of Tumoral Endothelium. Cancers (Basel) 2022;14:2743. [PMID: 35681724 DOI: 10.3390/cancers14112743] [Reference Citation Analysis]
6 Akman M, Belisario DC, Salaroglio IC, Kopecka J, Donadelli M, De Smaele E, Riganti C. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J Exp Clin Cancer Res 2021;40:28. [PMID: 33423689 DOI: 10.1186/s13046-020-01824-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhang Y, Long J, Ren J, Huang X, Zhong P, Wang B. Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects. Front Oncol 2021;11:731441. [PMID: 34646772 DOI: 10.3389/fonc.2021.731441] [Reference Citation Analysis]
8 Sigal DS, Hermel DJ, Hsu P, Pearce T. The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets. Future Oncol 2022;18:117-34. [PMID: 34734786 DOI: 10.2217/fon-2021-1110] [Reference Citation Analysis]
9 Zhou J, Hu Y, Zhu W, Nie C, Zhao W, Faje AT, Labelle KE, Swearingen B, Lee H, Hedley-whyte ET, Zhang X, Jones PS, Miller KK, Klibanski A, Zhou Y, Soberman RJ. Sprouting Angiogenesis in Human Pituitary Adenomas. Front Oncol 2022;12:875219. [DOI: 10.3389/fonc.2022.875219] [Reference Citation Analysis]
10 Liu X, Wang Y, Zheng Y, Duan D, Dai F, Zhou B. Michael acceptor-dependent pro-oxidative intervention against angiogenesis by [6]-dehydroshogaol, a pungent constituent of ginger. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174990] [Reference Citation Analysis]
11 Li W, Xu R, Zhu B, Wang H, Zhang H, Hu L, Li H, Sun X, Yu H, Wang D. Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma. Head Neck 2021. [PMID: 34931399 DOI: 10.1002/hed.26962] [Reference Citation Analysis]
12 Kola P, Metowogo K, Manjula SN, Katawa G, Elkhenany H, Mruthunjaya KM, Eklu-Gadegbeku K, Aklikokou KA. Ethnopharmacological evaluation of antioxidant, anti-angiogenic, and anti-inflammatory activity of some traditional medicinal plants used for treatment of cancer in Togo/Africa. J Ethnopharmacol 2022;283:114673. [PMID: 34571077 DOI: 10.1016/j.jep.2021.114673] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xuan W, Khan F, James CD, Heimberger AB, Lesniak MS, Chen P. Circadian regulation of cancer cell and tumor microenvironment crosstalk. Trends Cell Biol 2021:S0962-8924(21)00124-0. [PMID: 34272133 DOI: 10.1016/j.tcb.2021.06.008] [Reference Citation Analysis]
14 Campion O, Thevenard Devy J, Billottet C, Schneider C, Etique N, Dupuy JW, Raymond AA, Boulagnon Rombi C, Meunier M, Djermoune EH, Lelièvre E, Wahart A, Bour C, Hachet C, Cairo S, Bikfalvi A, Dedieu S, Devy J. LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis. Biomedicines 2021;9:1430. [PMID: 34680548 DOI: 10.3390/biomedicines9101430] [Reference Citation Analysis]
15 Tang L, Xiong W, Zhang L, Wang D, Wang Y, Wu Y, Wei F, Mo Y, Hou X, Shi L, Xiong F, Zhang S, Gong Z, Liao Q, Xiang B, Zhang W, Zhou M, Li X, Li G, Guo C, Zeng Z. circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene 2021;40:307-21. [PMID: 33122825 DOI: 10.1038/s41388-020-01531-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
16 Niland S, Eble JA. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment. Int J Mol Sci 2020;22:E238. [PMID: 33379400 DOI: 10.3390/ijms22010238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Liu B, Chen J, Shang F, Lian M, Shen X, Fang J, Wu X. Tumor-Derived Exosome FGD5-AS1 Promotes Angiogenesis, Vascular Permeability, and Metastasis in Thyroid Cancer by Targeting the miR-6838-5p/VAV2 Axis. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/4702855] [Reference Citation Analysis]
18 Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021;19:423. [PMID: 34915901 DOI: 10.1186/s12951-021-01174-y] [Reference Citation Analysis]
19 Li L, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Liao Q, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. What are the applications of single-cell RNA sequencing in cancer research: a systematic review. J Exp Clin Cancer Res 2021;40:163. [PMID: 33975628 DOI: 10.1186/s13046-021-01955-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Virumbrales-muñoz M, Ayuso JM, Loken JR, Denecke KM, Rehman S, Skala MC, Abel EJ, Beebe DJ. Microphysiological model of the renal cell carcinoma to inform anti-angiogenic therapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121454] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jiang X, Xu Y, Chen D, Wang M, Qiu M, Xiong L, Zhang L, Yu H, Xiong Z. A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome. Int J Gen Med 2022;15:311-23. [PMID: 35027841 DOI: 10.2147/IJGM.S349210] [Reference Citation Analysis]
22 Li LJ, Chang WM, Hsiao M. Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts. Pharmaceuticals (Basel) 2021;14:194. [PMID: 33673471 DOI: 10.3390/ph14030194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lei L, Ma B, Xu C, Liu H. Emerging Tumor-on-Chips with Electrochemical Biosensors. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116640] [Reference Citation Analysis]
24 Singh P, Yadav M, Niveria K, Verma AK. Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. Exploration of Medicine. [DOI: 10.37349/emed.2022.00072] [Reference Citation Analysis]
25 Xie S, Wang Y, Huang Y, Yang B. Mechanisms of the antiangiogenic effects of aspirin in cancer. Eur J Pharmacol 2021;898:173989. [PMID: 33657423 DOI: 10.1016/j.ejphar.2021.173989] [Reference Citation Analysis]
26 Wang Z, Cao B, Ji P, Yao F. Propofol inhibits tumor angiogenesis through targeting VEGF/VEGFR and mTOR/eIF4E signaling. Biochem Biophys Res Commun 2021;555:13-8. [PMID: 33812053 DOI: 10.1016/j.bbrc.2021.03.094] [Reference Citation Analysis]
27 Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong W. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res 2021;40:81. [PMID: 33648534 DOI: 10.1186/s13046-021-01874-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
28 Kazakova O, Șoica C, Babaev M, Petrova A, Khusnutdinova E, Poptsov A, Macașoi I, Drăghici G, Avram Ș, Vlaia L, Mioc A, Mioc M, Dehelean C, Voicu A. 3-Pyridinylidene Derivatives of Chemically Modified Lupane and Ursane Triterpenes as Promising Anticancer Agents by Targeting Apoptosis. Int J Mol Sci 2021;22:10695. [PMID: 34639035 DOI: 10.3390/ijms221910695] [Reference Citation Analysis]
29 Zhou M, Lu W, Li B, Yuan X, Liu M, Han J, Liu X, Li A. Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA. Int J Biol Sci 2021;17:2884-98. [PMID: 34345214 DOI: 10.7150/ijbs.59891] [Reference Citation Analysis]
30 Sart S, Ronteix G, Jain S, Amselem G, Baroud CN. Cell Culture in Microfluidic Droplets. Chem Rev 2022. [PMID: 35179881 DOI: 10.1021/acs.chemrev.1c00666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tam SY, Law HK. JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation. Cancers (Basel) 2021;13:2196. [PMID: 34063627 DOI: 10.3390/cancers13092196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Luo R, Li Y, Wu Z, Zhang Y, Luo J, Yang K, Qin X, Wang H, Huang R, Wang H, Luo H. Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer. Front Surg 2022;9:871823. [DOI: 10.3389/fsurg.2022.871823] [Reference Citation Analysis]
33 Kumari S, Advani D, Sharma S, Ambasta RK, Kumar P. Combinatorial therapy in tumor microenvironment: Where do we stand? Biochim Biophys Acta Rev Cancer 2021;1876:188585. [PMID: 34224836 DOI: 10.1016/j.bbcan.2021.188585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Jin Z, Chenghao Y, Cheng P. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer. Front Pharmacol 2022;12:824531. [DOI: 10.3389/fphar.2021.824531] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 2021;20:7. [PMID: 33397409 DOI: 10.1186/s12943-020-01288-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
36 Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol 2021;11:23-45. [PMID: 34026577 DOI: 10.5662/wjm.v11.i3.23] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
37 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
38 Wang M, Jia J, Cui Y, Peng Y, Jiang Y. Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas. Brain Sci 2021;11:1529. [PMID: 34827528 DOI: 10.3390/brainsci11111529] [Reference Citation Analysis]
39 Belvedere R, Morretta E, Novizio N, Morello S, Bruno O, Brullo C, Petrella A. The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EVs. Biomolecules 2021;11:1758. [PMID: 34944403 DOI: 10.3390/biom11121758] [Reference Citation Analysis]
40 Shen R, Liu D, Wang X, Guo Z, Sun H, Song Y, Wang D. DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling. Front Cell Dev Biol 2021;9:828657. [PMID: 35265630 DOI: 10.3389/fcell.2021.828657] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Guo Y, Xie Y, Luo Y. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment. Front Immunol 2022;13:851004. [PMID: 35222443 DOI: 10.3389/fimmu.2022.851004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Baldi S, Khamgan H, Qian Y, Wu H, Zhang Z, Zhang M, Gao Y, Safi M, Al-Radhi M, Zuo YF. Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma. Front Oncol 2021;11:679334. [PMID: 34414106 DOI: 10.3389/fonc.2021.679334] [Reference Citation Analysis]
43 Li X, Geng X, Chen Z, Yuan Z. Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106218] [Reference Citation Analysis]
44 Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Exp Clin Cancer Res 2021;40:146. [PMID: 33926508 DOI: 10.1186/s13046-021-01952-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Khan RA, Hossain R, Roy P, Jain D, Mohammad Saikat AS, Roy Shuvo AP, Akram M, Elbossaty WF, Khan IN, Painuli S, Semwal P, Rauf A, Islam MT, Khan H. Anticancer effects of acteoside: Mechanistic insights and therapeutic status. Eur J Pharmacol 2021;916:174699. [PMID: 34919888 DOI: 10.1016/j.ejphar.2021.174699] [Reference Citation Analysis]
46 Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q, Tang Y, He Y, Liao Q, Li X, Wu X, Xiang B, Zhou M, Li Y, Li G, Li X, Zeng Z, Guo C, Xiong W. The influence of circular RNAs on autophagy and disease progression. Autophagy 2021;:1-14. [PMID: 33904341 DOI: 10.1080/15548627.2021.1917131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kudo-Saito C, Ozaki Y, Imazeki H, Hayashi H, Masuda J, Ozawa H, Ogiwara Y. Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers (Basel) 2021;13:554. [PMID: 33535613 DOI: 10.3390/cancers13030554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
48 Arora L, Pal D. Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression. Front Oncol 2021;11:596798. [PMID: 33763348 DOI: 10.3389/fonc.2021.596798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Miyachi K, Murakami Y, Inoue Y, Yoshioka H, Hirose O, Yamada T, Hasegawa S, Arima M, Iwata Y, Sugiura K, Akamatsu H. UVA causes dysfunction of ETBR and BMPR2 in vascular endothelial cells, resulting in structural abnormalities of the skin capillaries. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.01.007] [Reference Citation Analysis]
50 Hao N, Zhou Y, Li Y, Zhang H, Wang B, Liu X, Ren Y, He J, Zhou C, Tang X. Clinical Value and Potential Mechanisms of Oxysterol-Binding Protein Like 3 (OSBPL3) in Human Tumors. Front Mol Biosci 2021;8:739978. [PMID: 34738015 DOI: 10.3389/fmolb.2021.739978] [Reference Citation Analysis]
51 Li D, Tang J, Gao R, Lan J, Shen W, Liu Y, Chen Y, Sun H, Yan J, Nie Y, Luo N. PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer. J Cancer 2022;13:212-24. [PMID: 34976184 DOI: 10.7150/jca.66773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Armani G, Pozzi E, Pagani A, Porta C, Rizzo M, Cicognini D, Rovati B, Moccia F, Pedrazzoli P, Ferraris E. The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment. Microvasc Res 2021;138:104189. [PMID: 34062191 DOI: 10.1016/j.mvr.2021.104189] [Reference Citation Analysis]
53 Kim CW, Choi KC. Potential Roles of Iridoid Glycosides and Their Underlying Mechanisms against Diverse Cancer Growth and Metastasis: Do They Have an Inhibitory Effect on Cancer Progression? Nutrients 2021;13:2974. [PMID: 34578851 DOI: 10.3390/nu13092974] [Reference Citation Analysis]
54 Davis L, Recktenwald M, Hutt E, Fuller S, Briggs M, Goel A, Daringer N. Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy. Cancers (Basel) 2022;14:1259. [PMID: 35267567 DOI: 10.3390/cancers14051259] [Reference Citation Analysis]
55 Li S. Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma. Front Oncol 2021;11:664853. [PMID: 34094958 DOI: 10.3389/fonc.2021.664853] [Reference Citation Analysis]
56 Mandal S, Chakrabarty D, Bhattacharya A, Paul J, Haldar S, Pal K. miRNA regulation of G protein-coupled receptor mediated angiogenic pathways in cancer. Nucleus 2021;64:303-15. [DOI: 10.1007/s13237-021-00365-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Jiang X, Deng X, Wang J, Mo Y, Shi L, Wei F, Zhang S, Gong Z, He Y, Xiong F, Wang Y, Guo C, Xiang B, Zhou M, Liao Q, Li X, Li Y, Li G, Xiong W, Zeng Z. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma. Oncogene 2021. [PMID: 34725462 DOI: 10.1038/s41388-021-02079-8] [Reference Citation Analysis]
58 Jang H, Choi J, Park JK, Won G, Seol JW. Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition. Animals (Basel) 2021;11:1512. [PMID: 34071074 DOI: 10.3390/ani11061512] [Reference Citation Analysis]
59 Mulvey A, Muggeo-Bertin E, Berthold DR, Herrera FG. Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer. Front Immunol 2022;13:859785. [PMID: 35603186 DOI: 10.3389/fimmu.2022.859785] [Reference Citation Analysis]
60 de Melo Quintela B, Hervas-raluy S, Manuel Garcia Aznar J, Walker D, Wertheim KY, Viceconti M. A Theoretical Analysis of the Scale Separation in a Model to Predict Solid Tumour Growth. Journal of Theoretical Biology 2022. [DOI: 10.1016/j.jtbi.2022.111173] [Reference Citation Analysis]
61 Xu J, Ma L, Wang D, Yang J. Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-β/SMAD3 signaling pathway. BMC Mol Cell Biol 2022;23:18. [PMID: 35413833 DOI: 10.1186/s12860-022-00416-7] [Reference Citation Analysis]
62 Li H, Zhang Y, Shu H, Lv W, Su C, Nie F. Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies. Int J Pharm 2021;:121412. [PMID: 34942327 DOI: 10.1016/j.ijpharm.2021.121412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Park MS, Yang AY, Lee JE, Kim SK, Roe JS, Park MS, Oh MJ, An HJ, Kim MY. GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner. Cancer Lett 2021;521:294-307. [PMID: 34416337 DOI: 10.1016/j.canlet.2021.08.015] [Reference Citation Analysis]
64 Zhang S, Huang J, Zhang L, Gu J, Song Q, Cai Y, Zhong J, Zhong H, Deng Y, Zhu W, Zhao J, Deng N. Fermentation, Purification, and Tumor Inhibition of a Disulfide-Stabilized Diabody Against Fibroblast Growth Factor-2. Front Oncol 2021;11:585457. [PMID: 33718141 DOI: 10.3389/fonc.2021.585457] [Reference Citation Analysis]
65 Ferraguti G, Terracina S, Petrella C, Greco A, Minni A, Lucarelli M, Agostinelli E, Ralli M, de Vincentiis M, Raponi G, Polimeni A, Ceccanti M, Caronti B, Di Certo MG, Barbato C, Mattia A, Tarani L, Fiore M. Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents. Antioxidants 2022;11:145. [DOI: 10.3390/antiox11010145] [Reference Citation Analysis]
66 Wu Y, Wang D, Wei F, Xiong F, Zhang S, Gong Z, Shi L, Li X, Xiang B, Ma J, Deng H, He Y, Liao Q, Zhang W, Li X, Li Y, Guo C, Zeng Z, Li G, Xiong W. EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1. FASEB J 2020;34:16205-23. [PMID: 33094864 DOI: 10.1096/fj.202001508R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
67 Huang YH, Lian WS, Wang FS, Wang PW, Lin HY, Tsai MC, Yang YL. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of HIF-1α and ANGPT2. Int J Mol Sci 2022;23:1636. [PMID: 35163556 DOI: 10.3390/ijms23031636] [Reference Citation Analysis]
68 Zhou M, Wang B, Li H, Han J, Li A, Lu W. RNA-binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program. Cancer Sci 2021;112:3835-45. [PMID: 34219323 DOI: 10.1111/cas.15053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Jafari A, Babajani A, Sarrami Forooshani R, Yazdani M, Rezaei-Tavirani M. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside. Front Oncol 2022;12:819563. [PMID: 35280755 DOI: 10.3389/fonc.2022.819563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
70 Yang Z, Deng W, Zhang X, An Y, Liu Y, Yao H, Zhang Z. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies. Front Oncol 2021;11:789330. [PMID: 35083147 DOI: 10.3389/fonc.2021.789330] [Reference Citation Analysis]
71 Kuehlbach C, Hensler S, Mueller MM. Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model. Bioengineering (Basel) 2021;8:186. [PMID: 34821752 DOI: 10.3390/bioengineering8110186] [Reference Citation Analysis]
72 Guo X, Meng X, Liu R. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis. Pathol Res Pract 2021;227:153644. [PMID: 34634564 DOI: 10.1016/j.prp.2021.153644] [Reference Citation Analysis]
73 Li R, Song X, Guo Y, Song P, Duan D, Chen ZS. Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis. Front Oncol 2021;11:772915. [PMID: 34746014 DOI: 10.3389/fonc.2021.772915] [Reference Citation Analysis]
74 Lou Y, Shi Q, Zhang Y, Qi Y, Zhang W, Wang H, Lu J, Han B, Zhong H. Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals. Front Cell Dev Biol 2022;10:840466. [DOI: 10.3389/fcell.2022.840466] [Reference Citation Analysis]
75 Xu W, Jin J, Wu X, Ren Q, Farzaneh M. MALAT1-related signaling pathways in colorectal cancer. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02540-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Shi B, Xu FF, Xiang CP, Li CY, Fan P, Wang H. HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance. Front Pharmacol 2022;13:851401. [PMID: 35355718 DOI: 10.3389/fphar.2022.851401] [Reference Citation Analysis]
77 Matsumoto K, Noda T, Kobayashi S, Sakano Y, Yokota Y, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Eguchi H. Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma. Cancer Lett 2021;500:29-40. [PMID: 33307155 DOI: 10.1016/j.canlet.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]